CD147/Basigin Limits Lupus Nephritis and Th17 Cell Differentiation in Mice by Inhibiting the Interleukin‐6/STAT‐3 Pathway
Open Access
- 17 April 2015
- journal article
- systemic lupus-erythematosus
- Published by Wiley in Arthritis & Rheumatology
- Vol. 67 (8) , 2185-2195
Abstract
Objective: Interleukin‐17 (IL‐17)–producing T cells (Th17 cells) play critical roles in the pathogenesis of immune‐related diseases, including systemic lupus erythematosus. However, the fundamental mechanism regulating Th17 cell differentiation is not fully understood. Recently, we demonstrated that plasma levels of CD147/basigin (Bsg) in patients with lupus nephritis (LN) were closely associated with disease activity. but the molecular mechanism involving Bsg has been elusive. Here, we addressed the role of Bsg in the pathogenesis of LN.Methods: Injections of pristane (2,6,10,14‐tetramethylpentadecane [TMPD]) were administered to Bsg−/− or Bsg+/+ mice to induce LN. The mice were killed 6 months after being injected, for histologic and biochemical analyses of the kidneys and spleens.Results: Pristane induced LN more strikingly in Bsg−/− mice than in Bsg+/+ mice, even though humoral autoimmunity was similarly increased in both genotypes. The increased number of Th17, but not Th1, Treg cells, was augmented in Bsg−/− mice. The expression of IL‐17 was also increased in the kidneys of Bsg−/− mice, in proportion to LN disease activity. Furthermore, treatment with anti–IL‐17 antibody reduced LN disease activity in Bsg−/− mice. Complementary to these phenotypes of Bsg−/− mice, Bsg expression was enhanced in activated CD4+ T cells in vivo and in vitro. Bsg deficiency selectively augmented in vitro differentiation of naive CD4+ T cells to Th17 cells and STAT‐3 phosphorylation during this differentiation. Moreover, STAT‐3 phosphorylation was suppressed by crosslinking of Bsg with its antibody.Conclusion: Bsg plays an indispensable role in Th17 cell differentiation as a negative regulator by suppressing the IL‐6/STAT‐3 pathway.Keywords
Funding Information
- Ministry of Health, Labor, and Welfare of Japan (Grant-in-Aid for Progressive Renal Diseases Research, Research on Intractable Disease) (90584681)
This publication has 48 references indexed in Scilit:
- Taming lupus—a new understanding of pathogenesis is leading to clinical advancesNature Medicine, 2012
- Systemic Lupus ErythematosusNew England Journal of Medicine, 2011
- T cells as therapeutic targets in SLENature Reviews Rheumatology, 2010
- Differentiation of Effector CD4 T Cell PopulationsAnnual Review of Immunology, 2010
- The IL-23/Th17 Axis Contributes to Renal Injury in Experimental GlomerulonephritisJournal of the American Society of Nephrology, 2009
- The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper CellsCell, 2006
- TGFβ in the Context of an Inflammatory Cytokine Milieu Supports De Novo Differentiation of IL-17-Producing T CellsImmunity, 2006
- Conversion of Peripheral CD4+CD25− Naive T Cells to CD4+CD25+ Regulatory T Cells by TGF-β Induction of Transcription Factor Foxp3 Journal of Experimental Medicine, 2003
- Divergent Pro- and Antiinflammatory Roles for IL-23 and IL-12 in Joint Autoimmune InflammationJournal of Experimental Medicine, 2003
- Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brainNature, 2003